2008
What to do with “Surprise” N2?: Intraoperative Management of Patients with Non-small Cell Lung Cancer
Detterbeck F. What to do with “Surprise” N2?: Intraoperative Management of Patients with Non-small Cell Lung Cancer. Journal Of Thoracic Oncology 2008, 3: 289-302. PMID: 18317073, DOI: 10.1097/jto.0b013e3181630ebd.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerMediastinal lymph node dissectionLymph node dissectionMediastinal lymph nodesPositive prognostic factorCell lung cancerAdjuvant therapyNode dissectionLung resectionLymph nodesMalignant involvementPrognostic factorsIntraoperative managementLung cancerPatientsConflicting dataResectionTherapyCancerDiseaseDissectionComprehensive review
2003
Invasive Staging* The Guidelines
Detterbeck FC, DeCamp MM, Kohman LJ, Silvestri GA. Invasive Staging* The Guidelines. CHEST Journal 2003, 123: 167s-175s. PMID: 12527576, DOI: 10.1378/chest.123.1_suppl.167s.Peer-Reviewed Original ResearchConceptsInvasive staging proceduresTransbronchial needle aspirationTransthoracic needle aspirationStaging procedureNeedle aspirationInvasive staging testsMediastinal lymph nodesFine-needle aspirationInvasive stagingLow morbidityLymph nodesMalignant involvementMediastinal nodesRadiographic stagingLung cancerStaging testsEndoscopic ultrasoundMultidisciplinary discussionPhysiologic considerationsFalse negative rateMediastinoscopyParticular riskLow false negative rateReasonable alternative